Abstract
This study investigates the potential synergistic effect of Cranberry (Vaccinium oxycoccos) extract and Amoxicillin-Clavulanic acid in enhancing antibacterial effectiveness and combating resistance. The main objectives of this study are do determine the MIC and FIC values for Amoxicillin-Clavulanic Acid and Vaccinium oxycoccos extract on different bacterial strains, and therefore to evaluate the synergistic effect of compounds combined. Vaccinium oxycoccos extract is rich in proanthocyanidins, phenolic acids, anthocyanins, vitamin C, and triterpene compounds, and has demonstrated antibacterial, antifungal, and anti-inflammatory properties. This study specifically evaluates its potential to inhibit biofilm formation by gram-negative bacteria. Amoxicillin, a semi-synthetic penicillin, is combined with Clavulanic acid, a β-lactamase inhibitor, to treat various bacterial infections. However, the rising antimicrobial resistance challenges the efficacy of this antibiotic combination. The effectiveness of combining antibiotics and natural substances in inhibiting bacterial growth can vary among different bacteria. This research emphasizes the importance of personalized treatment for each bacterial strain to effectively combat antibiotic-resistant infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Science and Research Archive
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
